GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Symbion Health Ltd (ASX:SY1) » Definitions » Cash, Cash Equivalents, Marketable Securities

Symbion Health (ASX:SY1) Cash, Cash Equivalents, Marketable Securities : A$196.68 Mil (As of Jun. 2007)


View and export this data going back to . Start your Free Trial

What is Symbion Health Cash, Cash Equivalents, Marketable Securities?

Symbion Health's quarterly cash, cash equivalents, marketable securities declined from Jun. 2005 (A$389.76 Mil) to Jun. 2006 (A$187.01 Mil) but then increased from Jun. 2006 (A$187.01 Mil) to Jun. 2007 (A$196.68 Mil).

Symbion Health's annual cash, cash equivalents, marketable securities declined from Jun. 2005 (A$389.76 Mil) to Jun. 2006 (A$187.01 Mil) but then increased from Jun. 2006 (A$187.01 Mil) to Jun. 2007 (A$196.68 Mil).


Symbion Health Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Symbion Health's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symbion Health Cash, Cash Equivalents, Marketable Securities Chart

Symbion Health Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.84 304.26 389.76 187.01 196.68

Symbion Health Semi-Annual Data
Jun95 Jun96 Jun97 Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.84 304.26 389.76 187.01 196.68

Symbion Health Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Symbion Health  (ASX:SY1) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Symbion Health Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Symbion Health's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Symbion Health (ASX:SY1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Symbion Health Ltd (ASX:SY1) » Definitions » Cash, Cash Equivalents, Marketable Securities
Comparable Companies
Traded in Other Exchanges
N/A
Address
Symbion Group Limited (SYB, formerly Mayne Group Limited) is a healthcare-focused company comprised of 5 divisions: Pathology; Medical Centres; Imaging; Pharmacy Services; and Symbion Consumer.

Symbion Health (ASX:SY1) Headlines

No Headlines